Your browser doesn't support javascript.
loading
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.
Ohlssen, David; Price, Karen L; Xia, H Amy; Hong, Hwanhee; Kerman, Jouni; Fu, Haoda; Quartey, George; Heilmann, Cory R; Ma, Haijun; Carlin, Bradley P.
Affiliation
  • Ohlssen D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, 07936, USA.
Pharm Stat ; 13(1): 55-70, 2014.
Article in En | MEDLINE | ID: mdl-24038897
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Meta-Analysis as Topic / Bayes Theorem Type of study: Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2014 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Meta-Analysis as Topic / Bayes Theorem Type of study: Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2014 Type: Article Affiliation country: United States